Glaucoma

Dr Claes Feinbaum investigates emerging evidence that CCT is an important predictor for the development of primary open-angle glaucoma (POAG), and that it may be relevant as a predictor of both glaucoma progression and response to IOP-lowering medication

Implanatation of multiple trabecular micro-bypass implants (iStent, Glaukos) in Schlemm's canal following phamoemulsification successfully and significantly reduced IOP for 12 months after implantation, as well as the number of medications required to maintain target IOP

Analyses of data from the Confocal Scanning Laser Ophthalmoscopy Ancilliary Study to the Ocular Hypertension Treatment study found rim area parameters changed significantly in the eyes that had progression to a primary open-angle glaucoma endpoint compared with eyes that did not.

Relationship between IOP and scleral response shows promise, says ophthalmologist

New findings from the ongoing African Descent and Glaucoma Evaluation Study (ADAGES) support previous results indicating that ancestry differences in visual function in healthy eyes are likely to be a sign of early disease.

A glaucoma specialist outlines the seven deadly sins of glaucoma management that, if avoided, can greatly reduce the number of people who go blind from glaucoma. These points include making sure that diagnosis occurs promptly and that patient compliance is stressed.

What's the role for SLT?

Monitoring IOP pressure during sleeping hours, two doctors test it out for themselves

Glaucoma is a final pathway of amny different disorders that can lead to a common pattern of optic nerve and visual field damage

Investigating the tolerability and IOP reduction effect of switching from latanoprost to tafluprost in patients exhibiting ocular surface side effects

The French EyeOP1 medical device, from EyeTechCare, is a novel and non-invasive treatment for glaucoma that is based on the use of high-intensity focused ultrasound (HIFUs). The product is set to become available at the end of 2010

Clinicians pose several arguments for trabeculectomy and tube-shunt surgery

Piecewise linear regression methods define structure-function relationship in glaucoma

FD-OCT adds accuracy to diagnostic assessment with measurement of GCC

Medical therapies are effective, but expensive too

Some observations on 'pseudoglaucomatous' discs and what to look out for

Can dietary manipulation modify the eye's ageing process?

Are we getting any closer to a cure or more targeted therapies?

Researchers are developing a minature intraocular pump for effective drug delivery to patients

To mark World Glaucoma Day here's how a grand European tour might look to patients with glaucoma.

A new technique which was found to improve surgical results for trabeculectomy

Glaucoma remains the world's leading cause of irreversible blindness, but 50% of people who have this devastating disease don't know it,” said Dr Clive Midgal, president of the European Glaucoma Society.

Greater, more consistent reductions seen throughout the day compared with brimonidine.

Simultaneous IOPg, IOPcc measurements may provide significant data about patient groups.

The Glaucoma Research Foundation (GRF) awarded the 2010 Shaffer Prize for Innovative Glaucoma Research to Kate Keller, PhD. Dr Keller is Research Assistant Professor, Department of Ophthalmology at Casey Eye Institute in Portland, Oregon.

Research claims that imaging devices can effectively support ophthalmologists with glaucoma diagnosis

Progress in glaucoma followed a slow, steady course in 2009, according to specialists

The Endoscopic CycloPhotocoagulation (ECP) technique provides an option for surgical glaucoma management, addressing ciliary aqueous production without the deeply destructive effects of classic ablative procedures. Dr Liegner explains

Alcon acquires Optinol and enters glaucoma surgical market.

The Scottish Medicines Consortium (SMC) has announced that Saflutan (tafluprost) has been accepted for restricted use within NHS Scotland for the reduction of elevated intraocular pressure (IOP) in open angle glaucoma and ocular hypertension